Cite Filings / PTHS / 0001753926-25-001081

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Pelthos Therapeutics Inc. Filed 2025-07-03 Acc 0001753926-25-001081

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-11-10 SCHEDULE 13D/A Beneficial Ownership Report
2025-07-03 SCHEDULE 13D/A Beneficial Ownership Report
2025-07-03 4 Director acquired 80,000 shares (conversion)
2025-07-03 4 Chief Financial Officer acquired 10,000 shares (conversion)
2025-07-03 4 Director acquired 1,500,000 shares (conversion)
2025-07-03 SCHEDULE 13D Beneficial Ownership Report
2025-07-03 4 10% owner acquired 1,500,000 shares (conversion)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…